FDA Actions

FDA Grants Full Approval to Encorafenib in Metastatic CRC

February 26, 2026

FDA OKs Subcutaneous Mosunetuzumab for Follicular Lymphoma

January 6, 2026

FDA Actions

FDA OKs Blood-Based Test to Help Diagnose Prostate Cancer

December 3, 2025

FDA Boxed Warnings Updates: October 2018

October 3, 2018

FDA Actions

Do Erythropoiesis-Stimulating Agents Have a Risk Evaluation and Mitigation Strategy? (FULL)

August 2, 2018

FDA Boxed Warning Updates: June 2018

June 27, 2018

FDA Actions

FDA Boxed Warning Updates: February 2018

February 15, 2018

FDA Actions

FDA Boxed Warning Updates: December 2017

December 28, 2017

FDA Actions

FDA Boxed Warning Updates

October 23, 2017

FDA Actions

Improved Access to Drug Safety Labeling Changes Information

May 10, 2017

FDA Actions

New and Updated FDA Boxed Warnings

March 3, 2017

FDA Actions

Recent FDA Boxed Warnings

February 7, 2017

FDA Actions